RSS Feeds
Search

Press releases

Press releases

Displaying 1..1 of 1 - per page
Order by
BioXell S.p.A. and Lay Line Genomics S.p.A. (LLG) today announced an exclusive, worldwide license agreement for the development of MNAC13, a novel humanized monoclonal antibody that binds to TrkA receptors, blocking the action of Nerve Growth Factor More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Your selection

Industry sector
Drug discovery del
Therapeutic target
Central Nervous System del
Neurodegenerative disorders del
Alzheimer's disease del
Year
2006 del

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us